Safety, Tolerability and Immunogenicity of Meningococcal C Conjugate Vaccine to Children 32 to 40 Months of Age

NCT00310635 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
241
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Novartis

Collaborators